Prolong Pharmaceuticals, LLC
USPTO PatentsView assignee record - 5 granted patents across 2 technology areas, recorded in grant years 2018–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Prolong ranks #49,796 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 2 technology areas.
- #49,796
- of 49,997 US assignees by volume
- 5th percentile
- by Innovation Score (18.5/100)
- 12.2
- avg claims per patent
- -33%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R49796 · US Corporation #49,796 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL
- GRANTS-MICRO 5 grants
- BOTTOM-DECILE #49,796/49,997
- PHOTO-FINISH Product Miniature
- CPC-NARROW A61K · 2 areas
- INNOV-LOW 18.5/100
- CLAIMS-RICH 12.2 claims/avg
- TYPE-USCORP US Corporation
- VEL-DOWN -33% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Product Miniature, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Prolong’s 18.5 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Prolong
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Prolong Pharmaceutic… · this assignee 19
Prolong Pharmaceutic… · this assignee
19 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Prolong's Innovation Score is 18.5/100 (5th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Prolong?
Each dot is one of Prolong’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Prolong’s own 12.2 claims/patent is at or below the 17.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Prolong's grants concentrate
Prolong Pharmaceuticals, LLC is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2019 (2 grants) versus a trough of 1 in 2018. By volume, Prolong sits between Product Miniature, Inc. and Prosetta Antiviral, Inc..
Who files at Prolong's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Product Miniature
Product Miniature, Inc.
5 patents
- Profitbricks
Profitbricks GmbH
5 patents
- Profound Position…
Profound Positioning Inc.
5 patents
- Prognomiq
PrognomIQ, Inc.
5 patents
- Prometheus Labora…
Prometheus Laboratories Inc.
5 patents
- Promixx
Promixx Ltd
5 patents
- Proseal UK
Proseal UK Limited
5 patents
- Prosetta Antiviral
Prosetta Antiviral, Inc.
5 patents
- Prolong Pharmaceu… ◀
Prolong Pharmaceuticals, LLC
5 patents
What this shows Prolong holds 5 patents at rank #49,833, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Prolong
By rank, the assignees closest to #49,833 in granted patent volume.
- Product Miniature, Inc. #49,829 · 5 patents
- Profitbricks GmbH #49,830 · 5 patents
- Profound Positioning Inc. #49,831 · 5 patents
- PrognomIQ, Inc. #49,832 · 5 patents
- Prometheus Laboratories Inc. #49,834 · 5 patents
- Promixx Ltd #49,835 · 5 patents
- Proseal UK Limited #49,836 · 5 patents
- Prosetta Antiviral, Inc. #49,837 · 5 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Prolong's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
Prolong's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
19 5th percentile higher than 5% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 20.0% |
| 2019 | 2 | 40.0% |
| 2020 | 2 | 40.0% |
Which technologies does Prolong Pharmaceuticals, LLC patent most?
Top 2 of 2 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Prolong Pharmaceuticals, LLC's patent record in context - here's where to go next.
- Prolong Pharmaceuticals, LLC's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #49,796 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Prolong Pharmaceuticals, LLC against Product Miniature, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 18.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.